Tumor recurrence is largely driven by infiltrating glioma cells that extend beyond the contrast-enhancing margin, which has traditionally served as the boundary for surgical resection. Supramaximal Resection in Glioblastoma: Expanding Surgical Boundaries in the Era of Precision Neuro-Oncology-A Systematic Review
The T2-FLAIR mismatch sign identifies isocitrate dehydrogenase-mutant 1p/19q noncodeleted gliomas with a high positive predictive value. Quantifying T2-FLAIR Mismatch Using Geographically Weighted Regression and Predicting Molecular Status in Lower-Grade Gliomas
Two-thirds of brain cancer patients receive their diagnosis only after presenting to the emergency department with more severe symptoms or neurological deficits. A multi-centre performance evaluation of a commercially developed liquid biopsy for the earlier detection of brain tumours
